Shamoon R, Nashwan AJ. Survival outcomes after laparoscopic gastric cancer surgery: The need for stage-specific insights. World J Gastrointest Surg 2025; 17(10): 110668 [DOI: 10.4240/wjgs.v17.i10.110668]
Corresponding Author of This Article
Abdulqadir J Nashwan, MSc, Department of Nursing, Hamad Medical Corporation, Al Sadd St, Doha 3050, Qatar. anashwan@hamad.qa
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Letter to the Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Oct 27, 2025 (publication date) through Oct 24, 2025
Times Cited of This Article
Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Surgery
ISSN
1948-9366
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Shamoon R, Nashwan AJ. Survival outcomes after laparoscopic gastric cancer surgery: The need for stage-specific insights. World J Gastrointest Surg 2025; 17(10): 110668 [DOI: 10.4240/wjgs.v17.i10.110668]
World J Gastrointest Surg. Oct 27, 2025; 17(10): 110668 Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.110668
Survival outcomes after laparoscopic gastric cancer surgery: The need for stage-specific insights
Richard Shamoon, Abdulqadir J Nashwan
Richard Shamoon, Research Volunteer, Hamad Medical Corporation, Doha 3050, Qatar
Abdulqadir J Nashwan, Department of Nursing, Hamad Medical Corporation, Doha 3050, Qatar
Author contributions: Shamoon R, Nashwan AJ contributed to writing the draft and critically reviewing the literature; All authors have read and approved the final manuscript.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Abdulqadir J Nashwan, MSc, Department of Nursing, Hamad Medical Corporation, Al Sadd St, Doha 3050, Qatar. anashwan@hamad.qa
Received: June 12, 2025 Revised: July 10, 2025 Accepted: August 13, 2025 Published online: October 27, 2025 Processing time: 134 Days and 14.6 Hours
Abstract
Gastric cancer remains one of the leading causes of cancer-related mortality worldwide. Advances in surgical techniques, especially laparoscopic surgery, have revolutionized the management of gastric cancer by reducing perioperative morbidity and enabling faster recovery. However, medium- to long-term survival remains understudied, and identifying factors that influence outcomes is essential for improving care. Gan et al’s study analyzes the 3-year survival outcomes and prognosis in patients with primary gastric cancer undergoing laparoscopic surgery. The study identifies the important variables associated with survival, including age, tumor node metastasis stage, tumor characteristics, surgical factors, and postoperative complications. While the study provides important data for clinical practice, further research is warranted to refine risk stratification and explore the role of emerging therapies.
Core Tip: Identifying key factors that influence survival after laparoscopic surgery for primary gastric cancer is crucial for optimizing patient outcomes. Moving forward, adopting a more individualized, multidisciplinary approach, risk stratification, and the integration of emerging therapies may further enhance survival and quality of life in these patients.
